从多个角度阐明血代谢物对乳腺癌的因果作用
Kun Fang1,2,3, Yuhang Zhou2,3,4, Shuo Wu2,3,5
1Central Laboratory, Cancer Hospital of China Medical University, Shenyang Liaoning Province, The People's Republic of China.
International journal of surgery (London, England)
|October 7, 2025
概括
血代谢物和乳腺癌风险是相关的. 该研究确定SPP1是一个关键基因,由酸调节,促进癌症生长,并提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 代谢学 代谢学 代谢学
- 遗传学 遗传学 是一个
背景情况:
- 代谢重编程在乳腺癌中很常见.
- 血代谢物和乳腺癌之间的因果关系尚不清楚.
研究的目的:
- 研究血代谢物对乳腺癌的因果关系.
- 确定乳腺癌治疗的潜在治疗点.
主要方法:
- 使用GWAS总结统计数据进行门德尔随机化 (MR) 和链接不平衡得分 (LDSC) 回归.
- 对强度的敏感性分析,用SNP和eQTL数据进行基因映射.
- 大量和单细胞RNA分析,并通过临床样本进行验证.
主要成果:
- 确定了七种显著的血代谢物;没有通过LDSC显著的遗传相关性.
- 乳腺癌中SPP1基因显著上调,并在外部队列中得到验证.
- 在单细胞-巨细胞中高SPP1表达促进癌细胞的增殖和迁移,由酸调节.
结论:
- SPP1是乳腺癌的潜在治疗点.
- 研究结果为个性化乳腺癌治疗策略提供了见解.
相关概念视频
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K


